| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-06 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-06 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |